Today: 9 June 2026
Joby Aviation (JOBY) stock slides premarket after $1.2 billion equity-and-convertible deal
29 January 2026
2 mins read

Joby Aviation (JOBY) stock slides premarket after $1.2 billion equity-and-convertible deal

NEW YORK, Jan 29, 2026, 07:16 EST — Premarket

Shares of Joby Aviation dropped almost 14% in premarket trading Thursday, following a sharp selloff late Wednesday after the electric air-taxi maker announced an upsized stock offering alongside a convertible bond deal. The stock last traded near $11.50, down from Wednesday’s close at $13.37.

This move counts because Joby continues to spend heavily before launching commercial service, and the size of the raise is enough to shift near-term supply and demand dynamics for the stock. Selling equity at a discount often pressures shares by boosting the number investors must digest.

Traders also keep an eye on a mechanical element in these deals. Convertible notes start as debt but can convert to stock down the line, and buyers frequently hedge by shorting shares, which can weigh on pricing and settlement.

Joby priced $600 million of common stock at $11.35 a share, alongside $600 million of 0.75% convertible senior notes due 2032. That boosts total gross proceeds to roughly $1.2 billion, up from the $1.0 billion it announced just a day earlier. Morgan Stanley is also handling a “delta offering” of about 5.29 million borrowed shares at the same $11.35 price, designed to help investors hedge. Joby clarified it won’t receive any proceeds from the borrowed-share sale. Joby Aviation, Inc.

The notes will carry a 0.75% interest rate and mature on Feb. 15, 2032, a company statement reported by Investing.com confirms. Investors can convert these notes at an initial price near $14.19 per share—above Wednesday’s closing price. Joby noted this conversion price implies roughly a 25% premium over the $11.35 delta-offering price.

Joby also executed “capped call” transactions—an options strategy designed to limit dilution from conversions—set with an initial cap price of $22.70 per share, according to a Seeking Alpha release. The company plans to allocate roughly $55 million of the note proceeds toward this capped call, cautioning that related hedging activity could cause volatility in the stock price around the deal. Seeking Alpha

Shares had already slid in extended trading Wednesday after Joby revealed its capital raise plan. According to a Reuters report shared on TradingView, the stock dropped roughly 12.3% after hours, hitting $11.73 following the news.

Joby previously stated it plans to use the proceeds to cover costs for aircraft certification, manufacturing, and gearing up for commercial operations. The remainder will go toward general corporate purposes. The company clarified that the stock and note offerings are independent of each other, though the delta offering and the note sale are linked and contingent on one another.

This is a well-worn pattern for investors in the electric vertical takeoff and landing (eVTOL) sector — emerging developers hitting the markets to bankroll lengthy engineering, certification, and production phases. The real issue isn’t just how much Joby raises now, but how far that money stretches before they need to raise again.

The downside is clear: issuing more shares now, combined with hedging activity, could keep the stock stuck or drive it down—even if the company’s fundamentals stay steady. Joby cautioned in its prospectus supplement that significant share sales and short selling linked to convertible-note hedging might weigh on its common stock price.

Traders will be eyeing whether JOBY holds around the $11.35 deal price when regular trading starts, and how much of the underwriters’ extra-allotment options get snapped up. Joby confirmed the offerings are set to settle on Feb. 2, pending usual closing conditions.

Stock Market Today

  • TJX Investment Growth: $1000 Ten Years Ago Now Worth How Much
    June 9, 2026, 10:22 AM EDT. A $1,000 investment in The TJX Companies (TJX) a decade ago would have grown significantly, reflecting the firm's strong performance as a leading off-price retailer. TJX operates about 4,900 stores across nine countries, including U.S. brands T.J. Maxx, Marshalls, and HomeGoods, as well as Canadian and European outlets. The company's opportunistic buying strategy, low-cost structure, and diversified global footprint have driven steady sales, enabling it to outperform many traditional retailers. Investors who held TJX stock for ten years benefited from its flexible business model and efficient distribution network. This example underscores the value of long-term investing with a company that continuously adapts to consumer trends and maintains vendor relationships, illustrating how patience and research can pay off in the retail sector.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Babcock share price today: BAB slips after fresh buyback filing, March year-end in focus
Previous Story

Babcock share price today: BAB slips after fresh buyback filing, March year-end in focus

Microsoft stock dives as AI spending bites; Nvidia steady, Meta jumps in split AI trade
Next Story

Microsoft stock dives as AI spending bites; Nvidia steady, Meta jumps in split AI trade

Go toTop